SCHEMBL7325641

SCHEMBL7325641

CO[C@H](COC(=O)CC(C)=O)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.46
ALDH1A1 P00352 1/20 0.40
TSHR P16473 1/20 0.40
PKM P14618 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2D6 P10635 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
ADRB2 P07550 1/20 0.39
ADRB1 P08588 1/20 0.39
ADRB3 P13945 1/20 0.39
PPARG P37231 1/20 0.38
MEN1 O00255 1/20 0.38
MGAM O43451 1/20 0.38
GAA P10253 1/20 0.38
SI P14410 1/20 0.38
MGAM2 Q2M2H8 1/20 0.38
MTNR1A P48039 1/20 0.38
MTNR1B P49286 1/20 0.38
MMP8 P22894 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7325650 1.00 KMT2A (0.46) KMT2AALDH1A1TSHRPKMCYP1A2
SCHEMBL7325646 1.00 KMT2A (0.46) KMT2AALDH1A1TSHRPKMCYP1A2
SCHEMBL22474313 0.84 KMT2A (0.44) KMT2AALDH1A1TSHRPKMCYP1A2
SCHEMBL13168067 0.83 ALDH1A1 (0.47) KMT2AALDH1A1TSHRPKMCYP1A2
SCHEMBL5413373 0.83 CA12 (0.47) KMT2AALDH1A1TSHRPKMCYP1A2
SCHEMBL11747029 0.81 KMT2A (0.44) KMT2AALDH1A1TSHRPKMCYP1A2
SCHEMBL13168062 0.79 APAF1 (0.42) KMT2AALDH1A1PKMCYP1A2CYP2D6
SCHEMBL13647304 0.78 KMT2A (0.46) KMT2AALDH1A1TSHRPKMCYP1A2
SCHEMBL23817190 0.78 KMT2A (0.44) KMT2AALDH1A1TSHRPKMCYP1A2
SCHEMBL8549771 0.78 ALDH1A1 (0.59) KMT2AALDH1A1TSHRADRB2ADRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0311053-A2 Ameliorant of cerebral circulation and optical isomer of nb-818, processes for its production and its use BANYU PHARMACEUTICAL CO., LTD. (JP) 1989-04-12 EP claimed
JP-1216972-A None JP disclosed
US-5494923-A Method of ameliorating cerebral circulation BANYU PHARMACEUTICAL CO., LTD. (JP) 1996-02-27 US disclosed
US-5444077-A Ameliorant of cerebral circulation and optical isomer of NB-818, processes for its use BANYU PHARMACEUTICAL CO., LTD. (JP) 1995-08-22 US disclosed
US-4988717-A Optically active 1,4-dihydropyridine esters useful for treating circulatory illnesses BAYER AKTIENGESELLSCHAFT (DE) 1991-01-29 US disclosed
JP-H01216972-A OPTICALLY ACTIVE 1,4-DIHYDROPYRIDINE DERIVATIVE, PRODUCTION AND USE THEREOF BANYU PHARMACEUT CO LTD 1989-08-30 JP disclosed
EP-0311053-A2 Ameliorant of cerebral circulation and optical isomer of nb-818, processes for its production and its use BANYU PHARMACEUTICAL CO., LTD. (JP) 1989-04-12 EP disclosed
EP-0211584-A1 Antihypertensive agents AMERICAN HOME PRODUCTS CORPORATION (US) 1987-02-25 EP disclosed
US-4618678-A 4-(2,3-dichloro-6-fluorophenyl)-1,4,5,6,7,8-hexahydro-2-methyl-5-oxo-1,7-naphthyridine-3-carboxylic acid 2-(2,3-dichlorophenoxy)ethyl ester AMERICAN HOME PRODUCTS CORPORATION (US) 1986-10-21 US disclosed
US-4596873-A 1,4,5,6,7,8-Hexahydro-2-alkyl-4-aryl-5-oxo-1,7-naphthyridine-3-carboxylic acid aromatic esters and pharmaceutically acceptable acid addition salts thereof useful as antihypertensive agents AMERICAN HOME PRODUCTS CORPORATION (US) 1986-06-24 US disclosed
US-4510310-A 1,4-Dihydro-2,6-dimethyl-4-(2'-chlorophenyl)-3,5-dicarboxylic acid,methyl or ethyl,trifluoroethyl ester BAYER AKTIENGESELLSCHAFT (DE) 1985-04-09 US disclosed